OverviewSuggest Edit

Zymergen is a company that researches, develops and manufactures microbes for industrial application. It develops molecules for biomedical coatings and adhesives that can be used as surgical glues either inside the body or on the skin to close a wound or to protect against infection. The company also integrates artificial intelligence algorithms and robotic genomic to search the microbial genome, discover new materials, commercialize new products and improve existing bio-manufactured products.

TypePrivate
Founded2013
HQEmeryville, CA, US
Websitezymergen.com
Employee Ratings3.2
Overall CultureF

Latest Updates

Employees (est.) (Jun 2021)798(+4%)
Job Openings86
Revenue (FY, 2020)$13.3 M(-13%)
Share Price (Jun 2021)$35(+2%)
Cybersecurity ratingAMore

Key People/Management at Zymergen

Josh Hoffman

Josh Hoffman

Chief Executive Officer and Co-Founder, Director
Judy Gilbert

Judy Gilbert

Chief People Officer
Jack Gold

Jack Gold

Chief Marketing Officer
Mina Kim

Mina Kim

Chief Legal Officer
Aaron Kimball

Aaron Kimball

Chief Technology Officer
Zach Serber

Zach Serber

Chief Science Officer and Co-Founder
Show more

Zymergen Office Locations

Zymergen has offices in Emeryville, Boise, Seattle and 千代田区
Emeryville, CA, US (HQ)
5980 Horton St #105
Boise, ID, US
12426 W Explorer Dr #250
Seattle, WA, US
1624 4th Ave #300
千代田区, JP
4/F East Tower 1-5-1 Otemachi First Square
Show all (5)

Zymergen Financials and Metrics

Summary Metrics

Founding Date

2013

Zymergen total Funding

$876.1 m

Zymergen latest funding size

$300 m

Time since last funding

9 months ago

Zymergen investors

Zymergen's latest funding round in September 2020 was reported to be $300 m. In total, Zymergen has raised $876.1 m
Show all financial metrics

Zymergen Revenue

Embed Graph
View revenue for all periods
Zymergen's revenue was reported to be $13.28 m in FY, 2020 which is a 13.8% decrease from the previous period.
USD

Revenue (FY, 2020)

13.3m

Revenue growth (FY, 2019 - FY, 2020), %

(13.8%)

Gross profit (FY, 2020)

(71.5m)

Gross profit margin (FY, 2020), %

(538.5%)

Net income (FY, 2020)

(262.2m)

EBIT (FY, 2020)

241.1m

Cash (31-Dec-2020)

210.2m
USDFY, 2019FY, 2020

Revenue

15.4m13.3m

Revenue growth, %

(14%)

Cost of goods sold

102.6m84.8m

Gross profit

(87.2m)(71.5m)
USDFY, 2019FY, 2020

Cash

143.6m210.2m

Accounts Receivable

2.4m2.5m

Prepaid Expenses

5.4m7.0m

Inventories

2.2m5.0m
USDFY, 2019FY, 2020

Net Income

(236.8m)(262.2m)

Depreciation and Amortization

15.2m18.7m

Inventories

(907.0k)(2.7m)

Accounts Payable

344.0k(4.4m)
USDFY, 2019

Revenue/Employee

22.1k

Debt/Equity

-0.2 x

Debt/Assets

0.4 x

Financial Leverage

-0.5 x
Show all financial metrics

Zymergen Operating Metrics

FY, 2020

Action Areas

4

Facility Space, sq. ft.

262 k

Patent Applications (US)

500

Patents Pending (US)

322
Show all operating metrics

Zymergen Acquisitions / Subsidiaries

Company NameDateDeal Size
enEvolvMarch 19, 2020
Radiant GenomicsJanuary 08, 2018

Zymergen Revenue Breakdown

Embed Graph

Zymergen revenue breakdown by geographic segment: 45.9% from United States of America, 35.7% from Asia and 18.4% from Europe

Human Capital Metrics

Source: github.com
Embed Graph
Show all human capital metrics

Zymergen Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Zymergen Online and Social Media Presence

Embed Graph

Zymergen Company Culture

  • Overall Culture

    F

    49/100

  • CEO Rating

    F

    53/100

  • Compensation

    C+

    69/100

Learn more on Comparably

Zymergen News and Updates

Zymergen Reports Preliminary First Quarter 2021 Financial Results

EMERYVILLE, Calif., May 24, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen”), one of the world’s leading biofacturing companies, today reported preliminary financial results for the first quarter ended March 31, 2021.

Zymergen to Present at UBS Global Healthcare Virtual Conference

EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen today announced the company will be participating in the upcoming UBS Global Healthcare Virtual Conference.

Zymergen to Report First Quarter 2021 Financial Results on May 24, 2021

EMERYVILLE, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen, today announced it will report financial results for the first quarter 2021 after market close on Monday, May 24th, 2021. The company’s management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:…

Zymergen Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

EMERYVILLE, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen”), one of the world’s foremost biofacturing companies, today announced the closing of its initial public offering of 18,549,500 shares of its common stock, including the full exercise by the underwriters of their optio…

In An Earth Day Test For Synthetic Biology Field, Zymergen Raises $500 Million In IPO

"I love the symbolism that we're going public on Earth Day," says Zymergen's Josh Hoffman. The synthetic biology company raised $500 million in an IPO set to value the company at more than $3 billion.

Zymergen Announces Pricing of Upsized Initial Public Offering

EMERYVILLE, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen”), one of the world’s foremost biofacturing companies, today announced the pricing of its initial public offering of 16,130,000 shares of its common stock at a public offering price of $31.00 per share. In addition, Zy…
Show more

Zymergen Blogs

How machine learning is changing the way we design products

Marian Farah’s team is honing in on better chemicals and materials — without the AI hype. The post How machine learning is changing the way we design products appeared first on Zymergen.

Bridging labs and software: A day in the life of a tech manager at Zymergen

As part of our We Make Tomorrow conversation series, Sheeva Haghighat shares how she builds digital solutions for biological problems. The post Bridging labs and software: A day in the life of a tech manager at Zymergen appeared first on Zymergen.

We Make Tomorrow: On becoming a biological data scientist

"I love that data science brings together people who are super motivated" reflects Senior Data Scientist Janet Matsen The post We Make Tomorrow: On becoming a biological data scientist appeared first on Zymergen.

At the intersection of technology and finance: In conversation with Christine Gorjanc

We sat down with newly appointed board member Christine Gorjanc to learn more about her career at the intersection of technology and finance, and her plans to help realize our company vision. The post At the intersection of technology and finance: In conversation with Christine Gorjanc appeared firs…

Digital screens of the future: Touch Taiwan 2021 in pictures

A visual tour of the materials and innovations going into your next digital device, featuring Hyaline Z2 and clear touch panel displays. The post Digital screens of the future: Touch Taiwan 2021 in pictures appeared first on Zymergen.

Scratching the surface of what’s possible with biology

Zymergen VP of Operations Jed Dean offers his perspective on using biology to scale discoveries into global solutions The post Scratching the surface of what’s possible with biology appeared first on Zymergen.
Show more

Zymergen Frequently Asked Questions

  • When was Zymergen founded?

    Zymergen was founded in 2013.

  • Who are Zymergen key executives?

    Zymergen's key executives are Josh Hoffman, Judy Gilbert and Jack Gold.

  • How many employees does Zymergen have?

    Zymergen has 798 employees.

  • What is Zymergen revenue?

    Latest Zymergen annual revenue is $13.3 m.

  • What is Zymergen revenue per employee?

    Latest Zymergen revenue per employee is $16.6 k.

  • Who are Zymergen competitors?

    Competitors of Zymergen include Biodesix, Ischemia Care and Scailyte.

  • Where is Zymergen headquarters?

    Zymergen headquarters is located at 5980 Horton St #105, Emeryville.

  • Where are Zymergen offices?

    Zymergen has offices in Emeryville, Boise, Seattle and 千代田区.

  • How many offices does Zymergen have?

    Zymergen has 5 offices.